LAS VEGAS, NV / ACCESS Newswire / June 10, 2025 / Hypha Labs, Inc. (OTCQB:FUNI), an Artificial Intelligence (AI) powered pioneer in functional mushroom sciences and the creator of the MicroPearls suite of products, is pleased to announce the filing of a new patent application with the United States Patent and Trade Office (USPTO) for its current suite of Artificial Intelligence (AI) powered techniques to create functional mushroom ingredients in its Mushroom Accelerator.
Hypha Labs' next-generation Mushroom Accelerator harnesses Artificial Intelligence and robust cloud connectivity to redefine how medicinal mushroom mycelium is cultivated. Each accelerator is wirelessly linked to a powerful cloud platform that analyzes real-time sensor data-covering temperature, oxygen, nutrient levels, and more-alongside a constantly growing database of successful harvests. The AI learning model uses these insights to automatically optimize every batch, providing users with real-time recommendations and precision control via an intuitive mobile app, accessible from anywhere. This means even home growers benefit from the collective learning of a global cultivation network, ensuring consistent, high-quality results with every cycle. What truly sets this system apart is its built-in over-the-air (OTA) update feature, which enables Hypha Labs to deliver ongoing software improvements and new AI capabilities directly to each bioreactor's onboard processor.
"It is a watershed moment for the Company that we have now arrived at a stage in our development that we are looking to fully protect our innovation and design as we inch closer to a product roll-out that truly personalizes and provides access to the magic of the mushroom to a potential market of millions of consumers," stated Stone Douglass, CEO, Hypha Labs. "We are most pleased to use the incredible and evolving power of Artificial Intelligence to refine one of nature's oldest and most revered ingredients… the mushroom."
About Hypha Labs, Inc.
The company has developed revolutionary, cutting-edge technology focused on new methods of producing the active ingredients found in a wide array of functional mushrooms using its patent-pending mushroom accelerators. The Company is positioning itself to play an important role in the burgeoning Functional Mushroom industry in addition to being a disruptive force in future and emerging mushroom opportunities. Visit us at HyphaLabs.com.
SAFE HARBOR FORWARD LOOKING STATEMENTS:
Ther Company wishes to remind the market that it is still engaged in an awareness program with Emerging Markets LLC as previously announced. This press release may contain forward looking statements that are based on current expectations, forecasts, and assumptions that involve risks as well as uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected, including statements related to the amount and timing of expected revenues related to our financial performance, expected revenue, contracts, and future growth for upcoming quarterly and annual periods. These risks and uncertainties are further defined in filings and reports by the Company with the U.S. Securities and Exchange Commission (SEC) and on the OTC Disclosure & News Service (OTCDNS). Actual results and the timing of certain events could differ materially from those projected in or contemplated by the forward-looking statements due to a number of factors detailed from time to time in our filings with the SEC and/or OTCDNS. Among other matters, the Company may not be able to sustain growth or achieve profitability based upon many factors including but not limited to the risk that we will not be able to find and secure construction contracts and the necessary assets that will enable us to become profitable. Reference is hereby made to cautionary statements set forth in the Company's most recent SEC and/or OTCDNS filings. We have incurred and will continue to incur significant expenses in our development stage, noting that there is no assurance that we will generate enough revenues to offset those costs in both the near and long term. New lines of business in the construction industry may expose us to additional legal and regulatory costs and unknown exposure(s), the impact of which cannot be predicted at this time. Words such as "estimate," "project," "predict," "will," "would," "should," "could," "may," "might," "anticipate," "plan," "intend," "believe," "expect," "aim," "goal," "target," "objective," "likely" or similar expressions that convey the prospective nature of events or outcomes generally indicate forward-looking statements. You should not place undue reliance on these forward-looking statements, which speak only as of this press release. Unless legally required, we undertake no obligation to update, modify or withdraw any forward-looking statements, because of new information, future events or otherwise.
From time to time, the Company may post new and material information on its website or through its social media profiles at the links below:
LN: https://www.linkedin.com/company/hypha-labs-inc/
FB: https://www.facebook.com/hyphalabs
IG: https://www.instagram.com/hyphalabsinc/
Twitter: https://x.com/Hypha_Labs
For more information about Hypha Labs visit HyphaLabs.com
For the Company's current Investor Presentation please visit www.HyphaLabs.com/deck
Investor and Media Relations:
Integrity MediaInc.
(888) 216-3595
team@integritymedia.com
SOURCE: Hypha Labs, Inc.
View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/hypha-labs-files-new-patent-application-for-its-suite-of-artificial-i-1037592
